New Zealand markets open in 1 hour 59 minutes

Zimmer Biomet Holdings, Inc. (ZBH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
114.95+2.46 (+2.19%)
At close: 03:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close112.49
Open114.41
Bid114.88 x 800
Ask114.89 x 800
Day's range113.41 - 115.15
52-week range100.39 - 149.28
Volume412,534
Avg. volume1,196,459
Market cap24.119B
Beta (5Y monthly)1.15
PE ratio (TTM)83.30
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.96 (0.85%)
Ex-dividend date24 Jun 2022
1y target estN/A
  • GlobeNewswire

    Akerna Announces Financial Results for First Quarter 2022

    Software revenue up 71%, total revenue up 73% year-over-yearDENVER, May 09, 2022 (GLOBE NEWSWIRE) -- Akerna (Nasdaq: KERN), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, today reported its unaudited financial results for the quarter ended March 31, 2022. "As demand for Akerna’s platforms from cannabis operators, regulators, and brands continues to widen, we

  • GlobeNewswire

    Akerna Corp. Reminds Stockholders of Upcoming Annual Meeting; Urges Stockholders to Vote FOR all Proposals

    DENVER, May 09, 2022 (GLOBE NEWSWIRE) -- Akerna Corp. (Nasdaq: KERN), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, urges stockholders to vote FOR proposals put forth in the proxy statement prior to the Company’s May 13, 2022 annual stockholder meeting to be held at 9:00 am eastern time. Akerna common stockholders on the March 31, 2022 record date are entit

  • GlobeNewswire

    ZimVie Completes Separation from Zimmer Biomet; Announces Board of Directors

    WESTMINSTER, Colo., March 01, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV) today announced its debut as an independent publicly traded company and the completion of its separation from Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH). This separation completes the path ZimVie began in 2021 when its former parent company announced its intention to separate its Dental and Spine businesses into one of the world’s newest and leading life sciences companies. ZimVie common stock began “regular